| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Sims Andrew John Hugh MacIntyre is a Chief Financial Officer at PLUS THERAPEUTICS, INC.. Recent SEC Form 4 filings include 9 buys and 0 sells.
Estimated insider holdings value: $652K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | PSTV Plus Therapeutics, Inc. | Chief Financial Officer | Buy | 20,000 | $0.51 | $10,200.00 | +41.5% | -52.5% | - | |
| Sep 10, 2024 | PSTV Plus Therapeutics, Inc. | Chief Financial Officer | Buy | 4,098 | $1.27 | $5,204.46 | +71.7% | +7.1% | -63.3% | |
| May 8, 2024 | PSTV Plus Therapeutics, Inc. | Chief Financial Officer | Buy | 4,902 | $2.04 | $10,000.08 | +601.5% | -29.5% | -72.7% | |
| Apr 26, 2022 | PSTV Plus Therapeutics, Inc. | Chief Financial Officer | Buy | 3,000 | $0.67 | $2,016.00 | +32.5% | -21.5% | -66.7% | |
| Mar 1, 2022 | PSTV Plus Therapeutics, Inc. | Chief Financial Officer | Buy | 2,000 | $1.10 | $2,199.80 | +27.7% | -49.1% | -70.9% | |
| Nov 2, 2021 | PSTV Plus Therapeutics, Inc. | Chief Financial Officer | Buy | 1,000 | $1.86 | $1,864.30 | +16.1% | -49.8% | -76.6% | |
| Oct 26, 2021 | PSTV Plus Therapeutics, Inc. | Chief Financial Officer | Buy | 2,000 | $1.67 | $3,338.80 | +47.3% | -48.8% | -73.7% | |
| Jul 28, 2021 | PSTV Plus Therapeutics, Inc. | Chief Financial Officer | Buy | 4,230 | $1.98 | $8,357.12 | +213.0% | -13.8% | -74.2% |